“…Recent studies have shown that the acetylation of many nonhistone proteins is associated with tumorigenesis, cancer cell proliferation, and immune function, which makes the regulation of protein acetylation a potential approach for the treatment of cancer (de Almeida Nagata et al, ; Dou, Zheng, Liu, & Tu, ; Liu, Li, Wu, & Cho, ). At present, acetylation has been shown to be involved in many important biological processes, including cell apoptosis (Cohen et al, ; S. S. Choi, Rhee, & Park, ), subcellular localization (Fujita, Fujiwara, Zenitani, & Yamashita, ; Ishfaq et al, ; Ito et al, ), DNA replication and repair (Al Emam, Arbon, Jeeves, & Kysela, ; Ghosh, Bohr, & Karmakar, ), DNA and protein interactions (Ugrinova, Pashev, & Pasheva, ), DNA transcription (Asano, Czuwara, & Trojanowska, ), protein stability (J. R. Choi, Lee, Shin, Choi, & Kang, ; J. Y. Choi, Ko, & Jo, ; Ge, Jin, Zhang, Yan, & Zhai, ; Wei et al, ), and so on. Regarding the regulation of protein stability, acetylation can compete with lysine ubiquitination and inhibit the proteasome degradation pathway mediated by ubiquitin, improving the stability and accumulation of proteins in cells that are involved in many physiological functions such as synaptic plasticity and cognitive function (G. Wang et al, ), tumor suppression (J. R. Choi et al, ), nuclear translocation, and transcriptional activity (Ge et al, ).…”